The Optimal Dosage of Intrathecal Morphine for Peripartum Analgesia

Stopped early · Not applicable · Has a placebo group

Conditions studied: Labor Pain

In brief

The purpose of this study is to determine the ideal dosage of intrathecal morphine for intra and post partum analgesia, while minimizing the side effect profile.

Key facts

Study ID

NCT01146457

Run by

Beth Israel Deaconess Medical Center

People needed

83

Starts

2010-07-01

Expected to finish

2015-01-01

Last updated by the study team

2017-04-25

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• singleton pregnancy,
• at least 36 weeks gestational age,
• active labor (≤ 5 cm dilation) requesting neuraxial analgesia,
• ASA I or II,
• not currently taking pain medications.

You may not qualify if…

• multiple gestation,
• preterm labor,
• systemic opioids in the past 4 hours,
• chronic pain syndromes,
• chronic opioid use,
• contraindications to regional anesthesia,
• allergies to opioids,
• significant co existing medical problems,
• severe pregnancy induced hypertension,
• sedatives,
• magnesium therapy,
• diabetes type 1.

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.